Evidence map›Paper›PMID 21757034›Full record

ArticleActa biomaterialia2011

Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.

A M Henslee, P P Spicer, D M Yoon, M B Nair, V V Meretoja, K E Witherel, J A Jansen, A G Mikos, F K Kasper

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Periosteum Mimetic Coating on Structural Bone AllograftsACS biomaterials science & engineering · 2020
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Development of a biodegradable bone cement for craniofacial applications.Journal of biomedical materials research. Part A · 2012
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

A M HensleeDepartment of Bioengineering, MS-142, Rice University, Houston, TX 77005, USA.
P P Spicer
D M Yoon
M B Nair
V V Meretoja
K E Witherel
J A Jansen
A G Mikos
F K Kasper
Rice University · USRadboud University Nijmegen · NL

Funding

In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
NIDCR NIH HHS R01 DE017441NIDCR NIH HHS R01-DE017441
6 · The paper itself

Abstract

In this study, a two-part bone tissue engineering scaffold was investigated. The scaffold consists of a solid poly(propylene fumarate) (PPF) intramedullary rod for mechanical support surrounded by a porous PPF sleeve for osseointegration and delivery of poly(dl-lactic-co-glycolic acid) (PLGA) microspheres with adsorbed recombinant human bone morphogenetic protein-2 (rhBMP-2). Scaffolds were implanted into critical size rat segmental femoral defects with internal fixation for 12 weeks. Bone formation was assessed throughout the study via radiography, and following euthanasia, via microcomputed tomography and histology. Mechanical stabilization was evaluated further via torsional testing. Experimental implant groups included the PPF rod alone and the rod with a porous PPF sleeve containing PLGA microspheres with 0, 2 or 8 μg of rhBMP-2 adsorbed onto their surface. Results showed that presence of the scaffold increased mechanical stabilization of the defect, as evidenced by the increased torsional stiffness of the femurs by the presence of a rod compared to the empty defect. Although the presence of a rod decreased bone formation, the presence of a sleeve combined with a low or high dose of rhBMP-2 increased the torsional stiffness to 2.06 ± 0.63 and 1.68 ± 0.56 N·mm, respectively, from 0.56 ± 0.24 N·mm for the rod alone. The results indicate that, while scaffolds may provide structural support to regenerating tissues and increase their mechanical properties, the presence of scaffolds within defects may hinder overall bone formation if they interfere with cellular processes.

Indexed as

AnimalsBiocompatible MaterialsBiodegradation, EnvironmentalBiomechanical PhenomenaBone Morphogenetic Protein 2Bone RegenerationFemurFumaratesHumansMicroscopy, Electron, ScanningOrgan SizeOsteogenesisPolypropylenesRatsRats, Inbred LewRecombinant ProteinsBiocompatible MaterialsBone Morphogenetic Protein 2Fumaratespoly(propylene fumarate)Polypropylenesrecombinant human bone morphogenetic protein-2Recombinant ProteinsTransforming Growth Factor beta

Identifiers

PMID21757034
PMCPMC3163689
OpenAlexW2159095423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.